E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
LYEL holding history
Lyell Immunopharma, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LYEL overviewAll 13F holders of LYELFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −21,829−100.0% | Sold out | Holders |
| Q3 2023 | 21,829 | $32.0K | <0.1% | +4,338+24.8% | Added | Holders |
| Q2 2023 | 17,491 | $56.0K | <0.1% | −11,247−39.1% | Reduced | Holders |
| Q1 2023 | 28,738 | $68.0K | <0.1% | −1,439−4.8% | Reduced | Holders |
| Q4 2022 | 30,177 | $105.0K | <0.1% | +15,986+112.6% | Added | Holders |
| Q3 2022 | 14,191 | $104.0K | <0.1% | +14,191 | New | Holders |